Molecular studies on zygomycetes fungi causing opportunistic infections

Reviews and Research in Medical Microbiology

Volumn 19, Issue 2, 2008, Pages 39-46

  Papp, Tamás ^a   Nyilasi, Ildikó ^a   Csernetics, Árpád ^a   Galgóczy, László ^a   Vágvólgyi, Csaba ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Genetic transformation; Molecular diagnosis; Mucor; Mucorales; Mucormycosis; Rhizopus; Species identification; Virulence factor; Zygomycosis

Indexed keywords

ANTIBIOTIC G 418; BENOMYL; DEFERASIROX; DEFEROXAMINE; FUNGAL DNA; HYGROMYCIN B; INTERNAL TRANSCRIBED SPACER; NEOMYCIN; OLIGOMYCIN; RNA 18S; RNA 28S;

AMINO ACID SEQUENCE; DNA SEQUENCE; FUNGAL VIRULENCE; FUNGUS IDENTIFICATION; GENETIC MANIPULATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; PATHOGENICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; ZYGOMYCETES;

EID: 67650091443     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e32831a40f9     Document Type: Review

References (84)

1. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twentyfirst century. Transpl Infect Dis 1999; 1:247-261.
2. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (Suppl 1):48-66.
3. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25:215-229.
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13:236-301.
5. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44:253-260.
6. Freifeld AG, Iwen PC. Zygomycosis. Semin Respir Crit Care Med 2004; 25:221-232.
7. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003; 16:607-612.
8. Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 2000; 44:57-62.
9. Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002; 46:15811582.
10. Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vitro activity of posaconazole against Mucor spp. in an immunosuppressed mouse model. Antimicrob Agents Chemother 2002; 46:2310-2312.
11. Tobon AM, Arango M, Fernandez D, Respetro A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 2003; 36:14881491.
12. Schwarz P, Bretagne S, Gantier J-C, Garcia-Hermoso D, Lortholary O, Dromer F, et al. Molecular identification of Zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 2006; 44:340-349.
13. Walsh TJ, Francesconi A, Kasai M, Chanock SJ. PCR and singlestranded conformational polymorphism for recognition of medically important opportunistic fungi. J Clin Microbiol 1995; 33:3216-3220.
14. Van Burik J-A, Myerson D, Schreckhise RW, Bowden RA. Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol 1998; 36:1169- 1175.
15. Kobayashi M, Togitani K, Machida H, Uemura Y, Ohtsuki Y, Taguchi H. Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae. Respirology 2004; 9:397-401.
16. Voigt K, Cigelnik E, O'Donnell K. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal-DNA sequence data. J Clin Microbiol 1999; 7:395 73964.
17. Wu Z, Tsumura Y, Blomquist G, Wang X-R. 18S rRNA gene variation among common airborne fungi, and development of specific oligonucleotide probes for the detection of fungal isolates. Appl Environ Microbiol 2003; 69:53895397.
18. Hall L, Wohlfiel S, Roberts GD. Experience with the MicroSeq D2 Large-Subunit Ribosomal Sequencing Kit for identification of filamentous fungi encountered in the clinical laboratory. J Clin Microbiol 2004; 42:622-626.
19. Balajee SA, Sigler L, Brandt ME. DNA and the classical way: identification of medically important molds in the 21st century. Med Mycol 2007; 45:475-490.
20. Nagao K, Ota T, Tanikawa A, TakaeY, Mori T, Udagawa S, et al. Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene. J Dermatol Sci 2005; 39:23-31.
21. Voigt K, Wöstemeyer J. Phylogeny and origin of 82 zygomycetes from all 54 genera of the Mucorales and Mortierellales based on combined analysis of actin and translation elongation factor EF-1 alpha genes. Gene 2001; 270:113-120.
22. O'Donnell K, Lutzoni FM, Ward TJ, Benny GL. Evolutionary relationships among mucoralean fungi (Zygomycota): evidence for family polyphyly on a large scale. Mycologia 2001; 93:286-296.
23. Tanabe Y, Saikawa M, Watanabe MM, Sugiyama J. Molecular phylogeny of Zygomycota based on EF-1 and RPB1 sequences: limitations and utility of alternative markers to rDNA. Mol Phyl Evol 2004; 30:438-149.
24. James TY, Kauff F, Schoch CL, Matheny PB, Hofstetter V, Cox C, et al. Reconstructing the early evolution of the fungi using a six gene phylogeny. Nature 2006; 443:818-822.
25. Nyilasi I, Papp T, Csernetics Á, Krizsán K, Nagy E, Vágvölgyi Cs. High-affinity iron permease (FTR1) gene sequences-based molecular identification of clinically important Zygomycetes. Clin Microbiol Inf 2008; 14:393-397.
26. Vagvölgyi Cs, Vastag M, Acs K, Papp T. Rhizomucor tauricus: a questionable species of the genus. Mycol Res 1999; 103:13181322.
27. Chakrabarti A, Ghosh A, Prasad GS, David JK, Gupta S, Das A, et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol 2003; 41:783-788.
28. Lemmer K, Losert H, Rickerts V, Just-Nübling G, Sander A, Kekrmann M-L, et al. Identification of Cunningnamella spec, by molecular methods. Mycoses 2002; 45 (Suppl 1):31-36.
29. Vastag M, Papp T, Kasza Zs, Vágvölgyi Cs. Intraspecific variation in two species of Rhizomucor assessed by random amplified polymorphic DNA analysis. J Basic Microbiol 2000; 40:269-277.
30. Vastag M, Papp T, Kasza Zs, Vágvölgyi Cs. Differentiation of Rhizomucor species by carbon source utilization and isoenzyme analysis. J Clin Microbiol 1998; 36:2153-2156.
31. Lukács Gy, Papp T, Nyilasi I, Nagy E, Vágvölgyi Cs. Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin. J Clin Microbiol 2004; 42:5400-5402.
32. Vágvölgyi Cs, Heinrich H, Ács K, Papp T. Genetic variability in the species Rhizopus stolonifer, assessed by random amplified polymorphic DNA analysis. Ant Leeuwenhoek 2004; 86:181 - 188.
33. Van Heeswijck R, Roncero MIG. High frequency transformation of Mucor with recombinant plasmid DNA. Carlsberg Res Commun 1984; 49:691-702.
34. Anaya N, Roncero MI. Transformation of a methionine auxotrophic mutant of Mucor circinelloides by direct cloning of the corresponding wild type gene. Mol Cen Genet 1991 ; 230:449455.
35. Benito EP, Diaz-Minguez JM, Iturriaga EA, Campuzano V, Eslava AP. Cloning and sequence analysis of the Mucor circinelloides pyrG gene encoding orotidine-5'-monophosphate decarboxylase: use of pyrG for homologous transformation. Gene 1992; 116:59-67.
36. Velayos A, Alvarez Ml, Eslava AP, Iturriaga EA. Interallelic complementation at the pyrF locus and the homodimeric nature of orotate phosphoribosyltransferase (OPRTase) in Mucor circinelloides. Mol Gen Genet 1998; 260:251-260.
37. Ruiz-Hidalgo MJ, Eslava AP, Alvarez Ml, Benito EP. Heterologous expression of the Phycomyces blakesleeanus photogene dehydrogenase gene (carB) in Mucor circinelloides. Curr Microbiol 1999; 39:259-264.
38. Iturriaga EA, Díaz-Minguez JM, Benito EP, Alvarez Ml, Eslava AP. Heterologous transformation of Mucor circinelloides with the Phycomyces blakesleeanus Ieu1 gene. Curr Genet 1992; 21:215-223.
39. Wolf AM, Arnau J. Cloning of glyceraldehyde-3-phosphate dehydrogenase-encoding genes in Mucor circinelloides (syn. racemosus) and use of the gpd1 promoter in recombinant protein production. Fung Genet Biol 2002; 35:21-29.
40. Appel KF, Wolff AM, Arnau J. A multicopy vector system for genetic studies in Mucor circinelloides and other zygomycetes. Mol Genet, Genomics 2004; 271:595-602.
41. Nyilasi I, Acs K, Papp T, Vágvölgyi Cs. Agrobacterium turnerarfens-mediated transformation of Mucor circinelloides. Folia Microbiol 2005; 50:415-120.
42. Papp T, Velayos A, Bartók T, Eslava AP, Vágvölgyi Cs, Iturriaga EA. Heterologous expression of astaxanthin biosynthesis genes in Mucor circinelloides. Appl Microbiol Biotechnol 2006; 69:526-531.
43. Wöstemeyer J, Burmester A, Wiegel C. Neomycin resistance as a dominantly selectable marker for transformation of the zygomycete Absidia glauca. Curr Genet 1987; 12:625-627.
44. Yamazaki H, Ohnishi Y, Takeuchi K, Mori N, Shiraishi N, Sakata Y, et al. Genetic transformation of a Rhizomucor pusillus mutant defective in asparagine-linked glycosylation: production of a milk-clotting enzyme in a less-glycosylated form. Appl Microbiol Biotechnol 1999; 52:401-109.
45. Wada M, Beppu T, Horinouchi S. Integrative transformation of the zygomycete Rhizomucor pusillus by homologous recombination. Appl Microbiol Biotechnol 1996; 45:652-657.
46. Monfort A, Cordero L, Maicas S, Polaina J. Transformation of Mucor miehei results in plasmid deletion and phenotypic instability. FEMS Microbiol Lett 2003; 224:101-106.
47. Liou CM, Yanai K, Horiuchi H, Takagi M. Transformation of a Leū mutant of Rhizopus niveus with the leuA gene of Mucor circinelloides. Biosci Biotechnol Biochem 1992; 56:1503-1504.
48. Takaya N, Yanai K, Horiuchi H, Ohta A, Takagi M. Cloning and characterization of the Rhizopus niveus leul gene and its use for homologous transformation. Biosci Biotechnol Biochem 1996; 60:448-452.
49. Yanai K, Horiuchi H, Takagi M, Yano K. Preparation of protoplasts of Rhizopus niveus and their transformation with plasmid DNA. Agric Biol Chem 1990; 54:2689-2696.
50. Horiuchi H, Takaya N, Yanai K, Nakamura M, Ohta A, Takagi M. Cloning of the Rhizopus niveus pyr4 gene and its use for the transformation of Rhizopus delemar. Curr Genet 1995; 27: 472-478.
51. MichielseCB, Salim K, Ragas P, Ram AFJ, Kudla B, Jarry B, et al. Development of a system for integrative and stable transformation of the zygomycete Rhizopus oryzae by Agrobacteriummediated DNA transfer. Mol Cenet Genomics 2004; 271:499510.
52. Skory CD. Homologous recombination and double-strand repair in the transformation of Rhizopus oryzae. Mol Cenet Genomics 2002; 268:397-406.
53. Skory CD. Repair of plasmid DNA used for transformation of Rhizopus oryzae by gene conversion. Curr Genet 2004; 45: 302-310.
54. Mertens JA, Skory CD, Ibrahim AS. Plasmids for expression of heterologous proteins in Rhizopus oryzae. Arch Microbiol 2006; 186:41-50.
55. Nyilasi I, Papp T, Csernetics A, Vágvölgyi Cs. Agrobacterium tumefaciens-mediated transformation of the zygomycete fungus, Backusella lamprospora. J Basic Microbiol 2008; 48:5 9-64.
56. González-Hernández GA, Herrera-Estrella L, Rocha-Ramírez V, Roncero MIG, Gutierez-Corona JF. Biolistic transformation of the Zygomycete Mucor circinelloides. Mycol Res 1997; 101: 953-956.
57. Arnau J, Jepsen LP, Stroman P. Integrative transformation by homologous recombination in the zygomycete Mucor circinelloides. Mol Gen Genet 1991; 225:193-198.
58. Arnau J, Stroman P. Gene replacement and ectopic integration in the zygomycete Mucor circinelloides. Mol Gen Genet 1993; 23:542-546.
59. Benito EP, Campuzano V, López-Matas MA, de Vicente JI, Eslava AP. Isolation, characterization and transformation, by autonomous replication of Mucor circinelloides OMPdecasedeficient mutants. Mol Gen Genet 1995; 248:126-135.
60. van Heeswijck, Roncero MIG, Jepsen LP. Genetic analysis and manipulation of Mucor species by DNA mediated transformation. In: Linskekns JH, Jackson JF, editors. Modern methods of plant analysis, vol. VII. Berlin: Springer Verlag; 1988. pp. 207220.
61. Vastag M, Kasza Zs, Acs K, Papp T, Schwab H, Vágvölgyi Cs. Cloning and sequences analysis of the glyceraldehyde-3phosphate dehydrogenase gene from the zygomycetes fungus Rhizomucor miehei. Ant Leeuwenhoek 2004; 86:111 -119.
62. Larsen GG, Appel KF, Wolff AM, Nielsen J, Arnau J. Characterisation of the Mucor circinelloides regulated promoter gpd1 P. Curr Genet 2004; 45:225-234.
63. Nyilasi I, Papp T, Takó M, Nagy E, Vágvölgyi Cs. Iron gathering of opportunistic pathogenic fungi. Acta Microbiol Immunol Hung 2005; 52:185-197.
64. Ko HS, Taguchi H, Takizawa K, Fukusima K, Kim HS. The enzymatic approach of zygomycosis: causing Mucorales. Kor J Med Mycol 2007; 12:9-17.
65. Partida-Martinez LP, Hertweck C. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 2005; 437:884-888.
66. Partida-Martinez LP, de Looß CF, Ishida K, Ishida M, Roth M, Buder K, et al. Rhizonin, the first mycotoxin isolated from the Zygomycota, is not a fungal metabolite but is produced by bacterial endosymbionts. Appl Environ Microbiol 2007; 73:793-797.
67. Wilson T, Rabie CJ, Fincham JE, Steyn PS, Schipper MA. Toxicity of rhizonin A, isolated from Rhizopus microsporus in laboratory animals. Food Chem Toxicol 1984; 22:275-281.
68. Jennessen J, Nielsen KF, Houbraken J, Lyhne EK, Schnurer J, Frisvad JC, et al. Secondary metabolite and mycotoxin production by the Rhizopus microsporus group. J Agrie Food Chem 2005; 53:1833-1840.
69. Chamilos G, Lewis RE, Kontoyiannis DP. Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: a hypothesis. Fung Genet Biol 2007; 44:88-92.
70. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39: 743-746.
71. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, et al. Zygomycosis in a tertiary care cancer center in the era of Aspergilius-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191:1350-1360.
72. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350:950-952.
73. Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartlet LA, Kilborn SB, Hoth PL, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39:588-590.
74. Ibrahim AS, Gebremariam T, Liu M, Chamilos G, Kontoyiannis DP, Kwon-Chung KJ, et al. Bacterial endosymbiosis does not contribute to mucormycosis pathogenesis [Abstract]. The American Society for Microbiology's 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2007 [Presentation #B-1443].
75. Ibrahim AS, Gebremariam T, Liu M, Chamilos G, Kontoyiannis DP, Mink R, et al. Bacterial endosymbiosis is widely present among Zygomycetes but does not contribute to mucormycosis pathogenesis. J Infect Dis 2008; 198:1083-1090.
76. Sugar AM. Agents of mucormycosis and related species. In: Mandeli GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995. pp. 2311-2321.
77. Ibrahim AS, Edwards JE Jr, Fu Y, Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 2006; 58:1070-1073.
78. Artis WM, Fountain JA, Deicher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982; 31:11101114.
79. Boelaert JR, de Locht M, Schneider Y-J. The effect of deferoxamine on different zygomycetes. J Infect Dis 1994; 169:231232.
80. Fu Y, Lee H, Collins M, Tsai H-F, Spellberg B, Edwards JE, et al. Cloning and functional characterization of the Rhizopus oryzae high affinity permease (rFTR) gene. FEMS Microbiol Lett 2004; 235:169-176.
81. Nyilasi I, Papp T, Lukács Gy, Nagy E, Vágvölgyi Cs. Cloning and sequence analysis of the nigh affinity iron permease (FTRI) gene from Rhizomucor miehei, a basis for functional analysis [abstract]. Mycoses 2005; 48 (Suppl 2):75.
82. Lin L, Spellberg BJ, Fu Y, Skory CD, Gebremariam T, Husseiny Ml, et al. High affinity iron permease is required for virulence of Rhizopus oryzae [abstract]. The American Society for Microbiology's 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2007 [Presentation #B1444].
83. Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny Ml, French SW, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007; 117: 2649-2657.
84. Kamei K. Animal models of zygomycosis: Absidia, Rhizopus, Rhizomucor, and Cunninghamella. Mycopathologia 2000; 152: 5-13.